Clinical trials
Completed Glomerulonephritis, IGA trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 7 |
| 2019 | 3 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 91 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Calliditas Therapeutics AB | 4 |
| Travere Therapeutics, Inc. | 4 |
| Centre Hospitalier Universitaire de Saint Etienne | 3 |
| Guangdong Provincial People's Hospital | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 3 |
| The George Institute | 3 |
| A. Manzoni Hospital | 2 |
| Amgen | 2 |
| Arrowhead Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulonephritis, IGA | 91 |
| Proteinuria | 16 |
| Kidney Diseases | 10 |
| Renal Insufficiency, Chronic | 8 |
| Glomerulonephritis | 7 |
| Glomerulosclerosis, Focal Segmental | 7 |
| Diabetic Nephropathies | 5 |
| Kidney Failure, Chronic | 5 |
| Glomerulonephritis, Membranous | 4 |
| Nephrosis, Lipoid | 4 |
Trials
Showing 51 to 75 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.